‹ Back to document
Comment from Novartis Pharmaceuticals Corporation
Anonymous
Analysis pending
See Attached
Attachments
Comment from Novartis Pharmaceuticals Corporation (PDF)
Envelope (PDF)
View on Regulations.gov →